Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on September 30, 2026

Sep. 30, 2026

Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings

Indeterminate GlobeNewswire

Sep. 30, 2026

Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

Sep. 30, 2026

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

Sep. 30, 2026

Green Circle Decarbonize Technology Limited Submits Tender Proposals for Chiller Replacement Engineering at MOS Centre and Air-Conditioning Retrofit & Operation and Maintenance at Nan Fung Centre in Hong Kong

Indeterminate GlobeNewswire

Sep. 30, 2026

MEXC Leads SOL and DOGE Market-Price Liquidity in CoinGecko's 2026 CEX Report

Indeterminate GlobeNewswire

Sep. 30, 2026

Ocugen to Participate in Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia

Indeterminate GlobeNewswire

Sep. 30, 2026

Classiq Introduces Fault Tolerance Engine to Bridge Quantum Applications and Fault-Tolerant Hardware

Indeterminate GlobeNewswire

Sep. 30, 2026

EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application

Indeterminate GlobeNewswire

Sep. 30, 2026

More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research

Indeterminate GlobeNewswire

Sep. 30, 2026

GlobalFoundries Announces Conference Call to Review Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 30, 2026

FactSet Reports Results for Fourth Quarter and Fiscal 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Indeterminate GlobeNewswire

Sep. 30, 2026

Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury

Indeterminate GlobeNewswire

Sep. 30, 2026

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Sep. 30, 2026

Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Sep. 30, 2026

Vema Hydrogen Expands Canadian Team as Pilot Testing Advances, Appointing Quebec-based Stephane Dallaire as CFO

Indeterminate GlobeNewswire

Sep. 30, 2026

10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher

Indeterminate GlobeNewswire

Sep. 30, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

Indeterminate GlobeNewswire

Sep. 30, 2026

Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer

Indeterminate GlobeNewswire